MAPT and tauopathy: We here develop a biosensor assay using HEK293 cells overexpressing full-length, wild-type 0N3R and/or 0N4R tau, which responds sensitively to brain-derived tau seeds and exhibits isoform-specificity for either 3R or 4R tauopathies.